A Randomized, Double-Blind, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of QPI-1002 For the Prevention of Major Adverse Kidney Events(MAKE) in Subjects at High Risk for Acute Kidney Injury(AKI) Following Cardiac Surgery(Prot#QRK3

Project: Research project

Project Details

Effective start/end date5/2/195/2/22


  • CTI Clinical Trial and Consulting Services (Prot#QRK309)
  • Quark Pharmaceuticals, Inc. (Prot#QRK309)